nonprescription drugs advisory committee october 20, 2005

8

Nonprescription Drugs Advisory Committee October 20, 2005 Open Public Hearing Speakers

Upload: ursala

Post on 22-Feb-2016

31 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

DESCRIPTION

Nonprescription Drugs Advisory Committee October 20, 2005. Open Public Hearing Speakers. Donald A. Goldman, M.D. Sally Bloomfield, BPharm, PhD Chairman and Scientific Advisory Board Member, IFH Hon. Professor, London School of Hygiene and Tropical Medicine. Lawton Seal, PhD - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Nonprescription Drugs Advisory Committee October 20, 2005

Nonprescription Drugs Advisory CommitteeOctober 20, 2005

Open Public Hearing Speakers

Page 2: Nonprescription Drugs Advisory Committee October 20, 2005

Donald A. Goldman, M.D.

Page 3: Nonprescription Drugs Advisory Committee October 20, 2005

Sally Bloomfield, BPharm, PhDChairman and Scientific Advisory

Board Member, IFH Hon. Professor, London School of Hygiene and Tropical Medicine

Page 4: Nonprescription Drugs Advisory Committee October 20, 2005

Lawton Seal, PhDSr. Program Manager

Healthpoint R&D

Page 5: Nonprescription Drugs Advisory Committee October 20, 2005

Charles N. HaasDrexel University

Page 6: Nonprescription Drugs Advisory Committee October 20, 2005

Tammy LundstromTammy Lundstrom

Page 7: Nonprescription Drugs Advisory Committee October 20, 2005

Howard BochnekHoward Bochnek

Page 8: Nonprescription Drugs Advisory Committee October 20, 2005

Eugene C. Cole, DrPHEugene C. Cole, DrPHBrigham Young UniversityBrigham Young University

Provo, UtahProvo, Utah

FDA Briefing Document for Nonprescription Drugs Advisory … · 2013-07-31 · 1 . FDA Briefing Document for . Nonprescription Drugs Advisory Committee . Triamcinolone Acetonide Nasal

[Participant Name Participant Address1 Participant …...• Maternity clothes • Medicines and drugs from other countries • Nonprescription drugs and medicines (except insulin)

Cognitive Accessibility of OTC Drug Information Ruth S. Day / Duke University FDA Nonprescription Drugs Advisory Committee (9/25/06) Drug Facts Active

Chapter 14 Over-the-Counter Drugs. OTC Market OTC drugs in the United States have surpassed over $16 billion in yearly sales The perception that nonprescription

SDA/CTFA Topical Antimicrobial Coalition Presentation to FDA Nonprescription Drugs Advisory Committee March 23, 2005

Psychopharmacologic Drugs Advisory Committee Meeting · Psychopharmacologic Drugs Advisory Committee Meeting Tiffany R. Farchione, MD . ... acquisition/learning, and RAVLT- delayed

1 Romiplostim FDA Overview Oncologic Drugs Advisory Committee Meeting Oncologic Drugs Advisory Committee Meeting Faranak Jamali, MD March 12, 2008

Handbook of nonprescription drugs 16th ed the poet010019 2

DEFENDANT JENNIFER KING VASSEL’S BRIEF IN OPPOSITION TO ...psychrights.org/States/Wisconsin/WatsonvVassel/109-130918Response2InLi... · nonprescription or over-the-counter drugs),

Nonprescription Drugs Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee March 24, 2005 Rx Topical Corticosteroids HPA Axis

Nonprescription Orlistat GlaxoSmithKline Consumer Healthcare, Ltd New Drug Application (21-887) Joint Nonprescription Drugs Advisory Committee and Endocrinologic

GAO-09-245 Nonprescription Drugs: Considerations Regarding

1 Nonprescription Drugs AC Meeting March 23, 2005 Testing of Healthcare Antiseptic Drug Products Michelle M. Jackson, Ph.D. Microbiologist Division of

Gastrointestinal Drugs Advisory Committee€¦ · Gastrointestinal Drugs Advisory Committee Introductory Remarks NDA203214 Tofacitinib: treatment of adults with moderate to severely

Advisory Council on the Misuse of Drugs

Review of Reported Adverse Events and Poisonings Associated with Cough and Cold Products in Young Children Joint Meeting of the Nonprescription Drugs Advisory

Regulatory History and Attributes of Consumer Antiseptics Nonprescription Drugs Advisory Committee Meeting Silver Spring, Maryland October 20, 2005 Colleen

Behavioral and pharmacologic strategies for weight ... · Handbook of nonprescription drugs: An interactive approach to self‐care. 19thedition. Patient assessment Handbook of nonprescription

Dermatologic and Ophthalmic Drugs Advisory …€¦ · Dermatologic and Ophthalmic Drugs Advisory Committee Meeting . Briefing Document . Product: Rhopressa™ (netarsudil ophthalmic

1 OTC-TFM Monograph: Statistical Issues of Study Design and Analyses Thamban Valappil, Ph.D. Mathematical Statistician OPSS/OB/DBIII Nonprescription Drugs

High Option Section 5(f). Prescription Drug Benefits...• Drugs available without a prescription or for which there is a nonprescription equivalent available • Nonprescription medications

Excluded drug list - Kaiser Permanente · o Drugs used in the treatment of weight management* Medical supplies such as dressings and antiseptics Nonprescription drugs, unless otherwise

Joint Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committee Meeting January 23, 2006 Nonprescription Orlistat GlaxoSmithKline

Non-Prescription Mevacor ® Merck & Co., Inc. New Drug Application 21-213 Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committee

Food and Drug Administration Modernization Act ... - gpo.gov · Noninvasive blood glucose meter. ... National uniformity for nonprescription drugs and cosmetics. ... by striking ‘‘Service

Orlistat 60 mg NDA 21-887 Label Comprehension Study Joint Nonprescription Drugs Advisory Committee and Endocrine and Metabolic Drugs Advisory Committee

Antiviral Drugs Advisory Committee Meeting Briefing Document

GAO-09-245 Nonprescription Drugs: Considerations Regarding ... · nonprescription status, thus reducing consumers’ access to drugs that would otherwise have become available OTC,

M FFh= PmmT!p - cdc.gov · Most drugs (92 percent) were prescription drugs (Rx) with nonprescription or over-the-counter (OTC) drugs accounting for only 6 percent. (Table 4 shows

Over-the-Counter Drugs and Herbal Products. Over-the-Counter (OTC) Drugs Nonprescription drugs Account for more than 60% of all medications used in the

Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care (16th Edition)

Dermatologic and Ophthalmic Drugs Advisory Committee

Regulatory History of Pediatric Cough/Cold Products Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Pediatric Advisory Committee

The Advertising of Prescription and Nonprescription Drugs in Magazines

Mevacor 20 mg Joint Meeting Nonprescription Drugs and Endocrinologic and Metabolic Drugs Advisory Committees December 13, 2007 Andrea Leonard-Segal, M.D